# Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

> **NCT01217723** · PHASE3 · UNKNOWN · sponsor: **McMaster University** · enrollment: 198 (estimated)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **BIOLOGICAL:** Anti-Thymocyte Globulin (Rabbit)
- **OTHER:** Patients will receive a standard preparative regimen (i.e. one that does not contain Thymoglobulin)

## Key facts

- **NCT ID:** NCT01217723
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2010-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01217723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01217723, "Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01217723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*